Citadel Advisors’s EQONEX LIMITED Ordinary Shares EQOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-34,500
Closed -$14K 15943
2022
Q3
$14K Sell
34,500
-4,100
-11% -$2.69K ﹤0.01% 12192
2022
Q2
$32K Buy
38,600
+1,700
+5% +$2.27K ﹤0.01% 12190
2022
Q1
$83K Buy
36,900
+15,200
+70% +$28.9K ﹤0.01% 12457
2021
Q4
$41K Buy
21,700
+6,200
+40% +$24K ﹤0.01% 13363
2021
Q3
$50K Sell
15,500
-82,100
-84% -$417K ﹤0.01% 13377
2021
Q2
$639K Buy
97,600
+37,700
+63% +$262K ﹤0.01% 9463
2021
Q1
$657K Buy
+59,900
New +$907K ﹤0.01% 9093

Other funds holding EQOS

Citadel Advisors's EQOS Position: Q4 2022 in Review

Citadel Advisors sold out of EQONEX LIMITED Ordinary Shares (EQOS) in Q4 2022, closing a stake of 94,340 shares — an estimated $38K sold.

Citadel Advisors first reported a position in EQOS in Q1 2021 and held it in 6 quarters. The position peaked at $305K in Q1 2021. 1 fund tracked by Wall St. Rank holds EQOS as of Q4 2022.

  • Citadel Advisors reported no remaining EQONEX LIMITED Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 94,340 EQONEX LIMITED Ordinary Shares shares in Q4 2022, an estimated $38K.
  • Citadel Advisors first reported a position in EQONEX LIMITED Ordinary Shares in Q1 2021 and held it in 6 quarters.
  • Citadel Advisors's EQONEX LIMITED Ordinary Shares position peaked at $305K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held EQONEX LIMITED Ordinary Shares as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.